Introduction
============

Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia due to the impaired secretion and/or action of insulin (Chikhi et al., 2014[@B8]).Its prevalence is increasing in many populations all over the world. In 2011, there were 366 million cases with diabetes, and it is expected to increase up to 522 million by 2030(Whiting et al., 2011[@B47]). Hyperglycemia leads to alteration in metabolism of carbohydrate, protein, and fat (Wan et al., 2013[@B46]). These metabolic disorders induce long term damages and dysfunction of various organs includingeyes, kidneys, nerves, and blood vessels (Santaguida et al., 2005[@B32]).There are multiple pharmacological interventions to reduce the hyperglycemia.

Therapy has been based on insulin or drugs that stimulate insulin secretion (sulphonylureas and rapid-acting secretagogues), reducing hepatic glucose production (biguanides), delaying digestion and absorption of intestinal carbohydrate (alpha-glucosidase inhibitors), or improving insulin action in thiazolidinediones(Grossman et al., 2013[@B18]).Unfortunately, all of these therapies have various side effects such as gastrointestinal upset, weight changes, hypoglycemia, joint stiffness, kidney complications, and skin alterations(Nathan,2007[@B29]; Soccio et al., 2014[@B37]).

The prevalence of complementary and alternative medicine use among people with diabetes ranges from 17 to 72.8%. The most widely used therapies among diabetic populations are nutritional supplements, herbal medicine, nutritional advice, spiritual healing, and relaxation techniques. Evidence suggests that a high proportion of people with diabetes use these therapies concurrently with conventional health care services (Chang et al., 2007[@B6]).Natural compounds have been proposed for prevention and/or treatment of diabetes. They act viainsulin-like activity, promoting glucose transport, and glucose metabolism (Alberti et al., 2006[@B1]; Lee et al., 2006[@B24])

Plants of Brassicacea family play a major role in worldwide vegetable production and consumption. Among them,*Brassica rapa* (turnip) has been cultivated for many centuries across Europe expanding eventually to central and east Asia (Dixon, 2006[@B9]). Turnip parts (root, leave, and seed) have been used in traditional medicine commonly for the treatment of some diseases such as diabetes (Javadzadeh and Pouyan, 2010[@B20]).

Turnip leaf contains biologically active compounds such as flavonoids including isorhamnetin, kaempferol and quercetin glycosides, phenyl propanoid derivatives, indole alkaloids, and sterol glucosides (Romani et al.,2006[@B31]; Schonhof et al., 2007[@B33]).Several studies have been reported that polyphenols and flavonoids have beneficial effects particularly on diabetes (Limet al.,2006[@B25]).

However, the impact of turnip leaf in diabetes has not been elucidated. The present study was conducted to evaluate the possible hypoglycemic and hypolipidemic effects of aqueous extract of turnip leaf(AETL) in alloxan-induced diabetic rats.

Materials and Methods
=====================

**Plant collection and extract preparation**

The leaves of *Brassica rapa* were collected during December 2011 from south Khorasan province, Birjand, Iran. The leaves were identified by an expert botanist, and a voucher specimen (221) was kept in the herbarium of agricultural faculty of Birjand University, Birjand, Iran.

*Brassica rapa* leaves were allowed to dry in shade. Dried leaves were powdered by electric grinder (Moulinex AR1043-UK).Powdered leaves weremacerated in distilled water 1:10(w/v) for 2 days at room temperature. Afterwards, the mixture was filtered **(Blue Ribbon, Grade 589,** Germany), from which 10 ml of concentrated extract was transferred and dried in a Petri dish at a temperature of 40 **°**C. The yield of the dried extract was 15.7 g per 100 g of dried turnip leaves. In this study, aqueous extract was used because in folk medicine people consume the infusion of turnip leaf.

**Phytochemical screening**

In order to determine the presence of alkaloids, glycosides, flavones, saponins, and tannins, preliminary phytochemical study of the aqueous extract of turnip leaf was performed (Tiwani et al., 2011[@B43]).Polyphenol content was also determined spectrophotometricallyusing Folin-Ciocalteu\'s method as described by Zivkovic et al. (Zivkovic et al., 2006[@B50]). Gallic acid was used as standard to measure the total polyphenol content in the extract.

**Animals and drugs**

In this experimental study, male albino Wistar rats of body weight 180-220 g were obtained from Pastor Institute, Iran. Animals were housed in polyethylene cages at temperature 21-25 **°**C, 12 h light/dark cycle and relative air humidity 40-45%. Rats had continuous access to standard commercial food (JavanehCo, Iran) and tap water. The experimental procedure used in the present work was approved by the Ethic Committee of the animal laboratory of Birjand University of Medical Sciences (BUMS), Birjand, Iran.

Alloxan was obtained from Sigma Co,USA and metformin tablets from Merck Sante\' s.a.s., Lyon, France. Alloxan and metformin were freshly dissolved in normal saline solution for intraperitoneal and oral administration, respectively.

**Induction of diabetes and experimental design**

Diabetes was induced by an intraperitoneal injection of freshly prepared alloxan monohydrate dissolved in normal saline at the single dose of 150 mg/kgbody weight (bw) to overnight fasted rats. After 14 days of alloxan administration, the rats with fasting blood sugar (FBS) concentrations more than 350 mg/dl were allocated as severe diabetic (Etuk, 2010[@B12]).

40 male Wistar rats were randomly divided into five equal groups (four diabetic and one healthy group). Normal saline solution was administered orally in healthy and diabetic controls rats at the same volume. Metformin at the dose of 50 mg/kg bw was administrated orally in diabetic rats as positive control group. The extract was dissolved in normal saline and daily administered orally in diabetic rats at the doses of 200 and 400 mg/kg bw for 28 days. The selected doses in this study were similar to several other studies (Ezuruike and Prieto, 2014[@B13]).

**Estimation and blood samples**

Blood samples were obtained by amputation of the tail tip of 14-hour fasted rats. FBS concentrations were measured on1^st^, 14^th^, and 29^th^ days using a glucometer (AccuChek Active,Germany). On 29^th^ day, 24h after thelast administration, overnight fasted rats were anesthetized and blood samples were drawn from their heart. Total cholesterol(TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c), aspartate amino transferase (AST), and alanine amino transferase (ALT) were estimatedby the use of standard kits (Pars Azmun company, Iran) and auto-analyzer (Prestige 24i- Japan).

**Statistical analysis**

All the data were expressed as mean ± Standard Deviation (SD) except the values of AST and ALT which were shown as mean ± Standard Error of Mean (SEM). Data were analyzed using one-way ANOVA and tukey'spost-hoc test. Values were considered significantly different at p\<0.05.

Results
=======

There was a significant elevation of blood glucose, total cholesterol, triglyceride, LDL-c, AST, and ALT levels in diabetic control rats as compared with non-diabetic control group.

**Effect of AETL on blood glucose concentration in diabetic rats**

[Table1](#T1){ref-type="table"}shows significant elevation of glucose concentrations on the first dayamong investigation groups that received alloxan. After 14 days of administration, the extract at the dose of 400 mg/kg and positive control group that received metformin 50mg/kg significantly decreased (*p*\<0.001) blood glucose concentration compared with diabetic control rats but there was not a significant decrease in group 4 that was treated with 200 mg/kg bw of the extract. On the 29^th^ day, both doses of the extract and metformin significantly decreased (*p*\<0.001) blood glucose levels when compared with diabetic control group. There was no significant difference (p\>0.05) between groups metformin and the extract at the dose of 400mg/kg on the 29^th^ day.

**Effect of AELT on plasma AST and ALT activities in diabetic rats**

[Figure 1 (A)](#F1){ref-type="fig"} shows that the administration of AELTat the dose of 200 mg/kg bw did not change AST levels in diabetic rats, while it increased the level of AST at the dose of 400 mg/kg bw. Metformin at the dose of 50 mg/kg bw significantly decreased (*p*\<0.05) AST in diabetic rats.

[Figure 1(B)](#F1){ref-type="fig"} illustrates that the administration of AELT in both doses and metformin significantly decreased (p\<0.001) ALT levels compared to diabetic control rats.

###### 

Effect of *Brassica rapa*aqueous leaf extract on blood glucose concentration

                                        **Blood glucose concentration (mg/dl) Means±SD**                                                                                   
  ------------------------------------- -------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------------------
  1-Healthy                             8.22[†](#TFN2){ref-type="table-fn"}±101.62         5.74[†](#TFN2){ref-type="table-fn"}±100.87                                      4.94[†](#TFN2){ref-type="table-fn"}±103.25
  2-Diabetic control                    461.50 ± 47.07[\*](#TFN1){ref-type="table-fn"}     466.75 ± 48.73[\*](#TFN1){ref-type="table-fn"}                                  515.00 ± 88.80[\*](#TFN1){ref-type="table-fn"}
  3-Diabetic+metformin 50mg/kgbw        471.78 ±29.94[\*](#TFN1){ref-type="table-fn"}      170.87 ± 46.48[†](#TFN2){ref-type="table-fn"}                                   113.25 ± 14.05[†](#TFN2){ref-type="table-fn"}
  4-Diabetic+200mg/kg bw leaf extract   47.97[\*](#TFN1){ref-type="table-fn"}± 466.12      88.96[\*](#TFN3){ref-type="table-fn"}± 390.00                                   63.20[\*](#TFN1){ref-type="table-fn"}[†](#TFN2){ref-type="table-fn"}± 312.25
  5-Diabetic+400mg/kg bw leaf extract   36.01[\*](#TFN1){ref-type="table-fn"}± 469.62      127.77[\*](#TFN1){ref-type="table-fn"}[†](#TFN2){ref-type="table-fn"}± 272.87   100.61[†](#TFN2){ref-type="table-fn"}±188.62

p\<0.001 compared with normal control group,

p\<0.001 compared with diabetic control group

![Effect of the aqueous leaf extract of *Brassica rapa*on plasma aspartate amino transferase(AST)and alanine aminotransferase (ALT) activities in diabetic rats.Values are given as mean ± S.E.M, n=8. ^†^ p\<0.001 compared to diabetic control group](AJP-5-148-g001){#F1}

###### 

Antihyperlipidemic effect of aqueous leaf extract of *Brassia rapa* in diabetic rats.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Groups (n=8)**                       **Cholesterol**\                                **Triglyceride**\                               **HDL**\                                      **LDL**\
                                         **(mg/dl)**                                     **(mg/dl)**                                     **(mg/dl)**                                   **(mg/dl)**
  -------------------------------------- ----------------------------------------------- ----------------------------------------------- --------------------------------------------- -----------------------------------------------
  1-Healthy                              81.62± 12.29[†](#TFN4){ref-type="table-fn"}     73.75± 6.04[†](#TFN4){ref-type="table-fn"}      31.50 ± 5.07                                  30.62 ± 8.12[†](#TFN4){ref-type="table-fn"}

  2-Diabetic control                     112.25±21.68[\*](#TFN3){ref-type="table-fn"}    114.50 ± 5.39[\*](#TFN3){ref-type="table-fn"}   33.25 ± 5.77                                  55.12 ± 18.86[\*](#TFN3){ref-type="table-fn"}

  3-Diabetic+metformin 50mg/kg bw        112.25± 12.09[\*](#TFN3){ref-type="table-fn"}   85.50 ± 20.88                                   37.12 ± 3.06                                  51.87±11.77[\*](#TFN3){ref-type="table-fn"}

  4-Diabetic+200 mg/kg bw leaf extract   62.12± 12.07[†](#TFN4){ref-type="table-fn"}     109.25 ± 9.42[\*](#TFN3){ref-type="table-fn"}   22.78 ± 4.32[†](#TFN4){ref-type="table-fn"}   17.75 ± 5.54[†](#TFN4){ref-type="table-fn"}
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

p\<0.001 compared with normal control group

p\<0.001 compared with diabetic control group

**Effect of AELT on plasma lipid profile in diabetic rats**

Administration of alloxan significantly elevated (*p*\<0.05) TC, TG, and LDL-c levels in diabetic rats ([Table 2](#T2){ref-type="table"}). There was no significant difference in HDL-c between diabetic control group and healthy control group. However, both doses of the extract significantly decreased (p\<0.05) total cholesterol and LDL--c levels but increased TG (especially at the dose of 400 mg/kg) and decreased HDL-c at both doses significantly (p\<0.05).

**Phytochemical screening of aqueous extract of turnip leaf**

The qualitative preliminary phytochemical screening showed that the aqueous extract of *Brassica rapa* contained flavonoids and tannins while saponins, glycosides, and alkaloids were absent. The mean of three parallel replicates of total polyphenol content in aqueous extract was 20.38 ± 0.72 mg/g gallic acid equivalent (GAE).

Discussion
==========

The present study showed that AELT has the ability to significantly decrease serum glucose and prevent to elevation of plasma ALT in a dose-dependent manner. It also prevented total cholesterol and LDL-c elevation at both doses in comparison to control diabetic rats.

According to our findings, AELTina dose-dependent manner significantly decreased HDL cholesterol and increased AST as well as triglyceride in diabetic rats.

Diabetes can be induced by pharmacological, surgical, or genetic manipulation in several animal species especially in rodents (Bliss,2007[@B5]). The majority of studies have usedpharmacological models in which streptozotocin or alloxan most frequently used for induction of diabetes (Shirwaikar et al.,2006[@B36]). Both drugs exert their diabetogenic action through reactive oxygen species, which cause rapid destruction of pancreatic β-cells (Szudelski, 2001[@B38]). In the present study, alloxanwas used to induce diabetes in animal as previously reported.

Blood glucose in our body is derived from three sources, i.e.,intestinal absorption of dietary carbohydrates, glycogenolysis, and gluconeogenesis (Giugliano et al., 2008[@B15]).Due to insulin deficiency (secretion or action) gluconeogenesis rises and subsequentlyliver production of glucose increases (Liu et al., 2010[@B26]). It has been suggested that in insulin-dependent diabetes, glucose uptake into skeletal muscle and adipose tissues is impaired (Gonzalez et al., 2006[@B16]). Moreover,in experimental diabetes models, intestinal carbohydrate digestion and absorption are altered which cause increasing of glucose uptake from the gut (Goto et al., 2012[@B17]).

Anti-hyperglycemic activity of turnip leaf may be due to possession of high levels of polyphenolic compounds and presence of flavonoids and tannins in this extract. Other studies have shown that some of anti-diabetic medicinal plants such as garlic, onion and fenugreek are rich inpolyphenol compounds(El-Demerdash et al., 2005[@B10];Jelodar et al., 2005[@B19]).In our study polyphenol amountof AELTwas 20.38 ± 0.72 mg/g GAEwhich iscomparable to garlic and onion (Lu et al., 2011[@B27]; Cheng et al.,2013[@B7]; Seasotiya et al.,2014[@B34]). Another study showed that edible parts of turnip (leave, root, and flower) contain 14 phenolic components and 6 organic acids (Fernandes et al., 2007[@B14]).

AMP-activated protein kinase (AMPK)pathway is an important sensor of cellular energy status and has a key role in the metabolic control.Therefore,it is considered as a new treatment for obesity, diabetes, and metabolic syndrome andis themain target for anti-diabetic drugs including metformin (Kumaret al.,2009[@B23]; Zang et al.,2006[@B51]).Some polyphenolsimprove glucose uptake in muscle cells and adipocytes by translocation of glucose transporter,GLUT4,to plasma membrane mainly through induction of the AMP-activated protein kinase pathway(Park et al.,2007[@B30]; Zhang et al., 2011[@B52]).Polyphenols also inhibit α-glucosidase and α-amylase,theenzymes responsible for digestion of dietary carbohydrate to glucose(Taderaet al.,2006[@B42]). Plant-food polyphenols have shown to attenuate hepatic gluconeogenesis via decreasing activity of glucose-6-phosphatase and phosphor endol pyruvate carboxykinase (PEPK) causing down-regulation of liver glucokinase (Waltner-Law et al., 2002[@B45]). Moreover,some polyphenols protect β-cells from oxidative damages by enhancing the natural antioxidant system and inhibition of lipid peroxidation (Szkudelski,2006[@B39]; Szkudelski &Szkudelska.,2001[@B40]).It was reported that flavonoids protect normal rat islets from alloxan, normalizes blood glucose levels, and promotes β-cell regeneration in islets of alloxan-treated rats (Vessal et al.,2003[@B44]). Exposure of isolated rat islets to certain flavonoids such as(y)-epicatechin or quercetin enhances insulin release by 44--70%(Tabatabaei-Malazy et al., 2013[@B41]).

In summary, as per the above-mentioned reasons, hypoglycemic activity of turnip leaf may be due to stimulating of peripheral glucose uptake in tissues, decreasing liver gluconeogenesis, regulating carbohydrate metabolism, and attenuating intestinal absorption of dietary carbohydrate. Therefore, turnip leaf chemical components may have exert regenerative effect on β cellsandstimulate these cells to produce more insulin or have some insulin-like substances.

Enzymes directly associated with the conversion of aminoacids to ketoacids are AST and ALT (Yin et al.,2011[@B49]). As a result of damage or toxicity to the liver (*e.g.,* in diabetic patients), these enzymes may leak from hepatocytes into circulationwhichcan lead to elevation in blood(Arobene et al.,2013[@B2]).In our study, similar to several other studies, AST and ALT were significantly elevated in diabetic rats in comparison to control ones (Karthikand Ravikumar,2011[@B22]; Erejuwa etal.,2012[@B11]).Despite the fact that aqueous extract of turnip leaf in adose-dependent manner caused significant reduction in the plasma ALT,AST levels were significantly increased in both doses even more than diabetic control group.

Hyperglycemia and Hyperlipidemia arethe common characteristics of alloxan-induced diabetes in rats(Asgary et al.,2014[@B3]).According to our findings, turnip leaf prevented elevation of total cholesterol and LDL-c in diabetic rats. 3-hydroxy-3-methyl-glutaryl coenzyme A reductase (HMG CoA reductase) is the rate-regulatory enzyme of cholesterol biosynthesis (Sharma et al.,2003[@B35]). Lipid lowering effect of the extract might be due to inhibitory effect of flavonoids and polyphenols compounds of turnip leaf on HMG CoA reductase which can lead to the reduction in cholesterol levelor by stimulating effect of glucose utilization in peripheral tissues (Yang et al., 2010[@B48]). Normally, lipoprotein lipase is activated by insulin.Therefore, insulin resistance/deficiency may result in extremely elevated triglyceride levels (Basciano et al., 2005[@B4]). In the present study, turnip leaf extract in both doses did not inhibit elevation of triglyceride in diabetic rats.

According to our knowledge, this is the first study that evaluated hypoglycemic efficacy of turnip leaf in alloxan-induced diabetic rats. Other studies that investigated the effects of root parts of *Brassica rapa* showed hypoglycemic effect and decreased ALT, AST, and cholesterol inthe treated animals (Jung et al., 2008[@B21]; Mohajeri et al, 2011[@B28]).

Finally, our results support the folk medicine recommendations to the use of *Brassica rapa* leaves as an anti-diabetic herbal medicine. These findings also provide a warning for its hypoglycemic toxicity potential (ASTandTG increasing andHDL lowering) for the diabetic peoples who consume this plant. Further studies should be carried out to confirm possible actions and mechanisms of the mentioned side effects ofturnip leaf.
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